Latest Information Update: 16 Sep 2014
At a glance
- Originator Alitair Pharmaceuticals Inc
- Class Aminobenzoic acids; Antitussives
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
- Available For Licensing Yes - Cough
Highest Development Phases
- Research Cough
Most Recent Events
- 16 Sep 2014 Early research in Cough in USA (PO)
- 16 Sep 2014 Benzonatate polacrilex is available for licensing as of 16 Sep 2014. http://www.alitair.com/